CENTENE CORPORATION

(CNC)
  Report
Delayed Nyse  -  04:03 2022-07-06 pm EDT
86.01 USD   +1.49%
06/30Centene corporation schedules 2022 second quarter financial results conference call
PR
06/30Health Net Initiatives Recognized by Institute for Medicaid Innovation for Addressing Social Determinants of Health to Improve Health Equity
PR
06/23GLOBAL MARKETS LIVE : Uber, Tesla, BMW, Revlon, Alibaba...
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/29/2022 06/30/2022 07/01/2022 07/05/2022 07/06/2022 Date
84.94(c) 84.61(c) 86.21(c) 84.75(c) 86.01 Last
2 935 590 2 516 069 1 972 886 2 776 392 2 506 339 Volume
+0.72% -0.39% +1.89% -1.69% +1.49% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 143 B - -
Net income 2022 2 544 M - -
Net Debt 2022 7 386 M - -
P/E ratio 2022 19,7x
Yield 2022 -
Sales 2023 142 B - -
Net income 2023 2 859 M - -
Net Debt 2023 3 747 M - -
P/E ratio 2023 17,2x
Yield 2023 -
Capitalization 49 569 M 49 569 M -
EV / Sales 2022 0,40x
EV / Sales 2023 0,38x
Nbr of Employees 72 500
Free-Float 95,6%
More Financials
Company
Centene Corporation specializes in health services. Revenues break down by activity as follows: - development of health insurance programs (96.2%): primarily for children, pregnant women, blind and disabled persons; - specialized services (3.8%): pharmaceutical services (claims processing, pharmacy network management, mail order sales, home delivery, analysis and clinical consulting services, etc.), health care... 
Sector
Managed Healthcare
Calendar
07/26 | 06:00amEarnings Release
More about the company
Ratings of Centene Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about CENTENE CORPORATION
06/30Centene corporation schedules 2022 second quarter financial results conference call
PR
06/30Health Net Initiatives Recognized by Institute for Medicaid Innovation for Addressing S..
PR
06/23GLOBAL MARKETS LIVE : Uber, Tesla, BMW, Revlon, Alibaba...
06/23Morgan Stanley Lowers Centene's Price Target to $103 From $112, Maintains Overweight Ra..
MT
06/23WALL STREET STOCK EXCHANGE : Powell did it again
06/22Deutsche Bank Adjusts Centene's Price Target to $91 From $88, Maintains Buy Rating
MT
06/21Centene Shares Rise on Credit Suisse Upgrade
MT
06/21Credit Suisse Upgrades Centene to Outperform from Neutral, Lifts PT to $88 from $86; Sa..
MT
06/17Centene Raises 2022 Outlook, Will Shrink Real Estate Footprint Due to More Flexible Wor..
MT
06/17WALL STREET STOCK EXCHANGE : Volatility is rife for Quadruple Witching Day
06/17SECTOR UPDATE : Health Care Stocks Edge Higher Premarket Friday
MT
06/17TRANSCRIPT : Centene Corporation - Special Call
CI
06/17CENTENE : ANNOUNCES INCREASED 2022 GUIDANCE AND VALUE CREATION UPDATES - Form 8-K
PU
06/17CENTENE CORP : Material Impairments, Regulation FD Disclosure, Other Events, Financial Sta..
AQ
06/17Centene Corporation Revises Revenue Guidance for the Fiscal Year 2022
CI
More news
News in other languages on CENTENE CORPORATION
06/21Les actions de Centene augmentent suite à la mise à niveau de Credit Suisse
06/21USA-Les valeurs à suivre à Wall Street (actualisé)
06/17Centene revoit à la hausse ses perspectives pour 2022 et réduira son empreinte immobili..
06/17MISE À JOUR SECTORIELLE : Les actions du secteur de la santé sont en hausse vendredi avant..
06/17Centene Corporation révise ses prévisions de revenus pour l'exercice 2022
More news
Analyst Recommendations on CENTENE CORPORATION
More recommendations
Chart CENTENE CORPORATION
Duration : Period :
Centene Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CENTENE CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Last Close Price 84,75 $
Average target price 95,95 $
Spread / Average Target 13,2%
EPS Revisions
Managers and Directors
Sarah McGinty London Vice Chairman & Chief Executive Officer
Brent Davis Layton President & Chief Operating Officer
Andrew Lynn Asher Chief Financial Officer & Executive Vice President
H. James Dallas Chairman
Mary V. Mason Vice President - Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
CENTENE CORPORATION4.62%49 569
UNITEDHEALTH GROUP3.04%474 002
ANTHEM, INC.4.84%114 983
CIGNA CORPORATION16.72%84 027
HUMANA INC.3.26%59 821
MOLINA HEALTHCARE, INC.-12.41%16 347